Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study.
- 2025-03
- RCT · n = 200
- Pharmacological research 213
- Xinye Li
- Xin Su
- Wanping Liang
- Li Wang
- Chao Yuan
- Juping Xu
- Yijun Zhang
- Yan Liu
- Ning Ma
- Fan Yang
- Yiyuan Yang
- Liyuan Tao
- Shipeng Sun
- Hongcai Shang
- Yanwei Xing
- PubMed: 39889867
- DOI: 10.1016/j.phrs.2025.107630
- High evidence
- Large Human Trial
- Clinical
The incidence of the primary efficacy outcome was 7.2 % (7/97) in the crocin group and 17.7 % (17/96) in the placebo group (P = 0.027).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes